Main Menu

Additional IDG associated funding opportunities are listed below.


Current RFAs:

PA-19-034: Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Posted: October 24, 2018, Open Date: December 05, 2018, 2018-11-26 Notice: NOT-OD-18-228 (NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications)
PA-19-033: Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Posted: October 24, 2018, Open Date: December 05, 2018, 2018-11-26 Notice: NOT-OD-18-228 (NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications)


Past RFAs:
RFA-RM-18-021: Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Posted: July 20, 2018, Application Due Date: October 26, 2018


RFA-RM-18-011: Cutting Edge Informatics Tools for Illuminating the Druggable Genome IU01 Clinical Trial Not Allowed) Posted: April 3, 2018, Application Due: July 9, 2018


Link to all targets for the RFA-RM-18-021 on Pharos: Follow Link (found by filter via Collections for ‘RFA-RM-18-021’)

IDG Consortium Current Projects




Questions for RFA-RM-18-021 contact DruggableGenome@mail.nih.gov